Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704900 | SCV000237234 | likely benign | not provided | 2020-10-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000460733 | SCV000542557 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2016-12-17 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769000 | SCV000900373 | likely benign | Cardiomyopathy | 2021-11-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002265671 | SCV002547645 | uncertain significance | not specified | 2022-05-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002415795 | SCV002729120 | likely benign | Cardiovascular phenotype | 2019-10-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV001704900 | SCV003818400 | uncertain significance | not provided | 2019-06-26 | criteria provided, single submitter | clinical testing |